Publicacións nas que colabora con Diego Bellido Guerrero (25)

2024

  1. A very-low-calorie ketogenic diet normalises obesity-related enhanced levels of erythropoietin compared with a low-calorie diet or bariatric surgery

    Journal of Endocrinological Investigation, Vol. 47, Núm. 11, pp. 2701-2713

2022

  1. Epigenetic Effects of Healthy Foods and Lifestyle Habits from the Southern European Atlantic Diet Pattern: A Narrative Review

    Advances in nutrition (Bethesda, Md.), Vol. 13, Núm. 5, pp. 1725-1747

  2. Reducing Metabolic Syndrome through a Group Educational Intervention Program in Adults with Obesity: IGOBE Program

    Nutrients, Vol. 14, Núm. 5

2021

  1. Effectiveness to promote weight loss maintenance and healthy lifestyle habits of a group educational intervention program in adults with obesity: IGOBE program

    Obesity Research and Clinical Practice, Vol. 15, Núm. 6, pp. 570-578

  2. The Southern european atlantic diet

    Minerva Endocrinology, Vol. 46, Núm. 2, pp. 145-160

2020

  1. Confusion in the nomenclature of ketogenic diets blurs evidence

    Reviews in Endocrine and Metabolic Disorders, Vol. 21, Núm. 1

  2. Hacia un score de la Dieta Atlántica

    Bases científicas de la Dieta Atlántica (Servicio de Publicaciones e Intercambio Científico), pp. 265-271

  3. Ketogenic diets as treatment of obesity and type 2 diabetes mellitus

    Reviews in Endocrine and Metabolic Disorders, Vol. 21, Núm. 3, pp. 381-397

2019

  1. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180

2018

  1. Resting metabolic rate of obese patients under very low calorie ketogenic diet

    Nutrition and Metabolism, Vol. 15, Núm. 1

2017

  1. Acid–base safety during the course of a very low-calorie-ketogenic diet

    Endocrine, Vol. 58, Núm. 1, pp. 81-90

  2. Body composition changes after very-low-calorie ketogenic diet in obesity evaluated by 3 standardized methods

    Journal of Clinical Endocrinology and Metabolism, Vol. 102, Núm. 2, pp. 488-498

  3. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

  4. Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: A marker of metabolic stress?

    International Journal of Obesity, Vol. 41, Núm. 10, pp. 1570-1578

  5. Prevención, diagnóstico y tratamiento de la obesidad. Posicionamiento de la Sociedad Española para el Estudio de la Obesidad de 2016

    Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 15-22

2016

  1. Effect of DHA supplementation in a very low-calorie ketogenic diet in the treatment of obesity: a randomized clinical trial

    Endocrine, Vol. 54, Núm. 1, pp. 111-122

  2. Obesity treatment by very low-calorie-ketogenic diet at two years: reduction in visceral fat and on the burden of disease

    Endocrine, Vol. 54, Núm. 3, pp. 681-690

  3. Short-Term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus

    Nutrition and Diabetes, Vol. 6, Núm. 9, pp. e230

2014

  1. Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity

    Endocrine, Vol. 47, Núm. 3, pp. 793-805

2013

  1. Índices antropométricos estimadores de la distribución adiposa abdominal y capacidad discriminante para el síndrome metabólico en población española

    Clinica e Investigacion en Arteriosclerosis, Vol. 25, Núm. 3, pp. 105-109